Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Australian Kidney Trials Network (AKTN) is a premier academic research organization focused on the design, conduct, and analysis of high-quality clinical trials in the field of nephrology. Hosted by the University of Queensland, the network provides the necessary infrastructure and expertise to facilitate multicenter trials aimed at improving outcomes for patients with chronic kidney disease, those on dialysis, and transplant recipients. AKTN collaborates extensively with global research institutions and industry partners to generate evidence-based solutions for kidney health. Their portfolio includes significant Phase 2 and Phase 3 trials that have influenced international clinical guidelines. By bridging the gap between research and clinical practice, the network plays a vital role in the global nephrology research community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Australian Kidney Trials Network.